Pamicell, Top Search Ranking... Stock Price Up 2.42%
Pamisell has ranked among the top searched stocks for 16 days in the past month.
As of 10:30 AM on the 6th, Pamisell is trading at 23,250 KRW, up 2.42% from the previous day. This represents a 23.34% increase compared to July 9. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net buyers of 102,014 shares. Over the past five days, individual investors have net sold 314,101 shares, while foreigners and institutions have net bought 256,517 shares and 20,008 shares, respectively.
On July 28, Pamisell was a market topic with the news of Moderna's Phase 3 clinical trial.
[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Samsung Electronics Union Reaches Tentative Agreement on Bonus Negotiations... "General Strike Postponed"
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Xi Jinping May Pay State Visit to North Korea as Early as Next Week"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement](https://cwcontent.asiae.co.kr/asiaresize/307/2026052022492353201A.jpg)
